Featured Research

from universities, journals, and other organizations

Rheumatoid arthritis patients in rich countries are three times more likely to receive biologic treatment than those in poor countries

Date:
June 18, 2010
Source:
European League Against Rheumatism
Summary:
There is significant disparity between "richer" and "poorer" countries in terms of access to biological treatments for rheumatoid arthritis (RA), according to results from a multinational study across four continents. Furthermore, findings from a separate study show that RA patients report the severity of their disease in the same way, irrespective of the country where they live.

There is significant disparity between 'richer' and 'poorer' countries in terms of access to biological treatments for rheumatoid arthritis (RA), according to results from a multinational study across four continents presented at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Furthermore, findings from a separate study show that RA patients report the severity of their disease in the same way, irrespective of the country where they live.

Results of a multinational study assessing whether macro-economic differences predict likelihood of treatment with a biologic showed that at the start of the study, RA patients in rich countries were three times more likely to have already received a biologic than those in poor countries (33% vs. 11.6%). Assessing the number of patients who had not received a biologic before the start of the study showed that the disparity between patients in rich and poor countries (20% vs. 14%) continued in the following four to five years.

Results of a second study showed that macro-economic status did not have an impact on RA patients' perceptions of their disease severity, as measured by several clinical measures collated within the Patient Reported Outcomes (PROs) index. PROs were compared to the DAS measure of disease activity (DAS28) and a significant association for both rich and poor countries was (beta coefficient 0.73 (0.70-0.77) vs. 0.78 (0.73-0.82) respectively) detected. This indicates that, regardless of macro-economic status of the country, patients in the study report disease severity in a consistent way.

"The QUEST-RA study involves researchers and patients from 32 countries worldwide, and is the first of this scale to reveal some interesting findings related to the impact of countries' macro-economic status on patients' perceptions of disease, as well as the healthcare options available to them," said Dr. Tuulikki Sokka, Jyväskylä Central Hospital, Jyväskylä, Finland and lead author of both analyses. "Our study group, QUEST-RA, was put together as a collaborative international study of RA and consequently, it sheds light on the true international variations and related economic factors that affect the treatment of RA across the world."

Professor Paul Emery, President of EULAR and arc Professor of Rheumatology, Leeds Institute of Molecular Medicine, University of Leeds, UK said "The results of these studies have painted a clear picture of the impact that macro-economy of the country has on the treatments available for patients. EULAR is a partnership organisation of people with arthritis and rheumatism in Europe and clinicians, researchers, health professionals and will continue to work for equal access to effective treatments across Europe."

Study design

The multinational study (SAT0515) assessed 3,394 RA patients (80% female, mean age 57 years) from 18 countries (11 rich, 7 poor) who had 4-5 year follow up data available for review, using the QUEST-RA database which includes patient data from 86 sites in 32 countries.

The second study (SAT0051) utilized all available data from 8,039 patients from the QUEST-RA database, (16 rich countries, 16 poor). PROs including measures to assess HAQ and visual analogue scales for pain (including the Routine Assessment of Patient Index Data3 (RAPID3) and Disease Activity Score (DAS28)) were used to gain feedback direct from the patient on the physical function limitations and experience of pain associated with their condition.


Story Source:

The above story is based on materials provided by European League Against Rheumatism. Note: Materials may be edited for content and length.


Cite This Page:

European League Against Rheumatism. "Rheumatoid arthritis patients in rich countries are three times more likely to receive biologic treatment than those in poor countries." ScienceDaily. ScienceDaily, 18 June 2010. <www.sciencedaily.com/releases/2010/06/100618102642.htm>.
European League Against Rheumatism. (2010, June 18). Rheumatoid arthritis patients in rich countries are three times more likely to receive biologic treatment than those in poor countries. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2010/06/100618102642.htm
European League Against Rheumatism. "Rheumatoid arthritis patients in rich countries are three times more likely to receive biologic treatment than those in poor countries." ScienceDaily. www.sciencedaily.com/releases/2010/06/100618102642.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) — West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) — A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) — Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) — Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins